Penumbra Total Assets 2014-2025 | PEN
Penumbra total assets from 2014 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
- Penumbra total assets for the quarter ending June 30, 2025 were $1.675B, a 9.14% increase year-over-year.
- Penumbra total assets for 2024 were $1.533B, a 1.49% decline from 2023.
- Penumbra total assets for 2023 were $1.556B, a 13.53% increase from 2022.
- Penumbra total assets for 2022 were $1.371B, a 10.18% increase from 2021.
| Penumbra Annual Total Assets (Millions of US $) |
|
|---|---|
| 2024 | $1,533 |
| 2023 | $1,556 |
| 2022 | $1,371 |
| 2021 | $1,244 |
| 2020 | $823 |
| 2019 | $666 |
| 2018 | $515 |
| 2017 | $477 |
| 2016 | $308 |
| 2015 | $264 |
| 2014 | $121 |
| 2013 | $71 |
| Penumbra Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2025-06-30 | $1,675 |
| 2025-03-31 | $1,593 |
| 2024-12-31 | $1,533 |
| 2024-09-30 | $1,479 |
| 2024-06-30 | $1,535 |
| 2024-03-31 | $1,580 |
| 2023-12-31 | $1,556 |
| 2023-09-30 | $1,468 |
| 2023-06-30 | $1,433 |
| 2023-03-31 | $1,395 |
| 2022-12-31 | $1,371 |
| 2022-09-30 | $1,322 |
| 2022-06-30 | $1,328 |
| 2022-03-31 | $1,302 |
| 2021-12-31 | $1,244 |
| 2021-09-30 | $973 |
| 2021-06-30 | $910 |
| 2021-03-31 | $841 |
| 2020-12-31 | $823 |
| 2020-09-30 | $810 |
| 2020-06-30 | $780 |
| 2020-03-31 | $664 |
| 2019-12-31 | $666 |
| 2019-09-30 | $614 |
| 2019-06-30 | $585 |
| 2019-03-31 | $569 |
| 2018-12-31 | $515 |
| 2018-09-30 | $501 |
| 2018-06-30 | $499 |
| 2018-03-31 | $490 |
| 2017-12-31 | $477 |
| 2017-09-30 | $459 |
| 2017-06-30 | $417 |
| 2017-03-31 | $418 |
| 2016-12-31 | $308 |
| 2016-09-30 | $297 |
| 2016-06-30 | $284 |
| 2016-03-31 | $275 |
| 2015-12-31 | $264 |
| 2015-09-30 | $259 |
| 2015-06-30 | $0 |
| 2015-03-31 | $0 |
| 2014-12-31 | $0 |
| 2014-09-30 | $0 |
| 2013-12-31 | $71 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $9.958B | $1.195B |
| Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $184.101B | 22.27 |
| Intuitive Surgical (ISRG) | United States | $172.528B | 71.51 |
| IDEXX Laboratories (IDXX) | United States | $51.032B | 53.11 |
| Edwards Lifesciences (EW) | United States | $45.970B | 30.47 |
| Alcon (ALC) | Switzerland | $43.470B | 29.38 |
| IQVIA Holdings (IQV) | United States | $32.732B | 18.50 |
| DexCom (DXCM) | United States | $31.694B | 47.54 |
| Mettler-Toledo (MTD) | United States | $27.012B | 32.06 |
| STERIS (STE) | Ireland | $24.087B | 25.64 |
| Waters (WAT) | United States | $17.226B | 23.66 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.782B | 0.00 |
| Hologic (HOLX) | United States | $14.962B | 16.21 |
| Sysmex ADR (SSMXY) | Japan | $8.391B | 26.66 |
| Masimo (MASI) | United States | $8.362B | 28.14 |
| Globus Medical (GMED) | United States | $8.137B | 18.77 |
| Teleflex (TFX) | United States | $5.297B | 8.55 |
| Glaukos (GKOS) | United States | $5.134B | 0.00 |
| TransMedics (TMDX) | United States | $4.283B | 65.10 |
| Integer Holdings (ITGR) | United States | $3.698B | 18.45 |
| LivaNova (LIVN) | United Kingdom | $2.909B | 16.65 |
| Veracyte (VCYT) | United States | $2.366B | 32.69 |
| Alphatec Holdings (ATEC) | United States | $2.347B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.265B | 0.00 |
| Artivion (AORT) | United States | $2.022B | 102.02 |
| Nihon Kohden (NHNKY) | Japan | $1.999B | 23.86 |
| Elekta AB (EKTAY) | Sweden | $1.847B | 17.28 |
| OPKO Health (OPK) | United States | $1.111B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.095B | 6.27 |
| Pulse Biosciences (PLSE) | United States | $1.055B | 0.00 |
| IRadimed (IRMD) | United States | $0.892B | 43.28 |
| Beta Bionics (BBNX) | United States | $0.750B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $0.732B | 0.00 |
| AxoGen (AXGN) | United States | $0.713B | 0.00 |
| SiBone (SIBN) | United States | $0.670B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.573B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.522B | 9.22 |
| Semler Scientific (SMLR) | United States | $0.500B | 4.01 |
| OrthoPediatrics (KIDS) | United States | $0.481B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.445B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.399B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.376B | 9.57 |
| Delcath Systems (DCTH) | United States | $0.373B | 88.75 |
| AngioDynamics (ANGO) | United States | $0.357B | 0.00 |
| RxSight (RXST) | United States | $0.347B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.319B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.280B | 19.35 |
| NeuroPace (NPCE) | United States | $0.279B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.277B | 0.00 |
| Neuronetics (STIM) | United States | $0.234B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.232B | 0.00 |
| 908 Devices (MASS) | United States | $0.225B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.219B | 0.00 |
| Inogen (INGN) | United States | $0.204B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.190B | 0.00 |
| Accuray (ARAY) | United States | $0.182B | 0.00 |
| CVRx (CVRX) | United States | $0.180B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.172B | 0.00 |
| LENSAR (LNSR) | United States | $0.152B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.140B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.137B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.116B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.111B | 0.00 |
| InspireMD (NSPR) | United States | $0.104B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.102B | 0.00 |
| Hyperfine (HYPR) | United States | $0.100B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.096B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.076B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.061B | 0.00 |
| Positron (POSC) | United States | $0.058B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.055B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.054B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.052B | 20.89 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.040B | 0.00 |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| DarioHealth (DRIO) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Tenon Medical (TNON) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.009B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| ReShape Lifesciences (HIND) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.14 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |